3Holman R.The UKPDS:implications for the dyslipidaemic patient.Acta Diabtol,2001,38:S9214.
4Feher M.Elkeles R Lipid modification and coronary heart disease intype 2 diabetes different from the general population.Heart,1999,81:10211.
5Expert Panel on Detection Evaluation,and Treatment of High Blood Cholesterol in Adults.Executive summary of the third report of the National Cholesterol Education Program(NCEP) Expert Panel on De2tection,Evaluation,and Treatment of High Blood Cholesterl in Adults (Adults Treatment Panel Ⅲ.JAMA,2004,285:248622497.
6胡大一,等.卫生部"十年百项"冠心病血脂干预技术推广项目,2009年5月.26页.
7心血管成都论坛?>>?继续教育?>>?中华医学会?>>正文2009-12-25.
8Herlitz J,Maln berg K.How to improve the cardiac prognosis for diabetes [J].Diabetes Cure,1999,22(suppl 2):89-96.
9Risk factor clustering in the insulin resistance syndrome and its relationship to cardiovascular disease in postmenopausal white,black,hispanic and Asian/Pacific Islander women [J].Metabolism,2003,52(3):362-371.
10Lloyd-Jones D,O' Donnell C,D'Agostino R,et al.Applicability of cholesterol-lowering primary prevention trials to a general population:the framingham heart study[J].Arch Intern Med,2001,161(7):949-954.
